Correction: A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01)

Detalles Bibliográficos
Autores principales: Kim, Hye Ryun, Jang, Joung Soon, Sun, Jong-Mu, Ahn, Myung-Ju, Kim, Dong-Wan, Jung, Inkyung, Lee, Ki Hyeong, Kim, Joo-Hang, Lee, Dae Ho, Kim, Sang-We, Cho, Byoung Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589698/
https://www.ncbi.nlm.nih.gov/pubmed/28903459
http://dx.doi.org/10.18632/oncotarget.20268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589698/
https://www.ncbi.nlm.nih.gov/pubmed/28903459
http://dx.doi.org/10.18632/oncotarget.20268

Ejemplares similares